Pmcs-010
Research payments
$2,614,000
Through program year 2025, $2,614,000 in research payments was reported against Pmcs-010, across 412 payments, paid by RxSight Inc.
- Paid by
- RxSight Inc
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $2,120,000 | 332 |
| 2024 | Research | $494,000 | 80 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Jonathan Seidenberg Havre De Grace, MD Named on 16 payments
- Peter Ririe American Fork, UT Named on 13 payments
- Marc Bosem Weston, FL Named on 11 payments
- Daniel Pluznik Washington, DC Named on 10 payments
- Ross Passo Hillsboro, OR Named on 10 payments
- Jay Schwartz Scottsdale, AZ Named on 10 payments
- Jonathan Walgama Longview, TX Named on 9 payments
- Peter Freeman Reno, NV Named on 8 payments
- Richard Kootman Peoria, AZ Named on 8 payments
- Gustavo Corrales Falls Church, VA Named on 7 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.